These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16431046)

  • 1. Effect of drug particle size in ultrasound compacted tablets. Continuum percolation model approach.
    Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 310(1-2):168-74. PubMed ID: 16431046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percolation thresholds in ultrasound compacted tablets.
    Caraballo I; Millán M; Fini A; Rodriguez L; Cavallari C
    J Control Release; 2000 Dec; 69(3):345-55. PubMed ID: 11102675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.
    Miranda A; Millán M; Caraballo I
    J Pharm Sci; 2007 Oct; 96(10):2746-56. PubMed ID: 17506514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the drug/excipient particle size ratio in the percolation model for tablets.
    Millán M; Caraballo I; Rabasco AM
    Pharm Res; 1998 Feb; 15(2):216-20. PubMed ID: 9523306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
    Fuertes I; Miranda A; Millán M; Caraballo I
    Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of sodium alginate as drug release modifier in matrix tablets.
    Liew CV; Chan LW; Ching AL; Heng PW
    Int J Pharm; 2006 Feb; 309(1-2):25-37. PubMed ID: 16364576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of controlled release inert matrices of naltrexone hydrochloride based on percolation concepts.
    Caraballo I; Melgoza LM; Alvarez-Fuentes J; Soriano MC; Rabasco AM
    Int J Pharm; 1999 Apr; 181(1):23-30. PubMed ID: 10370199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between drug percolation threshold and particle size in matrix tablets.
    Caraballo I; Millan M; Rabasco AM
    Pharm Res; 1996 Mar; 13(3):387-90. PubMed ID: 8692730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of drug load on dissolution behavior of tablets containing a poorly water-soluble drug: estimation of the percolation threshold.
    Wenzel T; Stillhart C; Kleinebudde P; Szepes A
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1265-1275. PubMed ID: 28398095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
    Grund J; Koerber M; Walther M; Bodmeier R
    Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical analysis of release kinetics of coated tablets containing constant and non-constant drug reservoirs.
    Zhou Y; Chu JS; Li JX; Wu XY
    Int J Pharm; 2010 Jan; 385(1-2):98-103. PubMed ID: 19879936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release behaviour of clozapine matrix pellets based on percolation theory.
    Aguilar-de-Leyva A; Sharkawi T; Bataille B; Baylac G; Caraballo I
    Int J Pharm; 2011 Feb; 404(1-2):133-41. PubMed ID: 21094234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution characteristics of cylindrical particles and tablets.
    Fukunaka T; Yaegashi Y; Nunoko T; Ito R; Golman B; Shinohara K
    Int J Pharm; 2006 Mar; 310(1-2):146-53. PubMed ID: 16414218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.